Clinical Trial Update: Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports outcomes of Cetrotide (cetrorelix) therapy to prevent ovarian hyperstimulation syndrome in women at high risk during infertil…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Ovarian Hyperstimulation Syndrome

Drugs mentioned

• CETROTIDE (cetrorelix acetate)

Snippet

Sponsor: Benha University | Conditions: Infertility | Phase 2, Phase 3 | Status: UNKNOWN | Results posted: 2017-01-31